妊娠前半期子痫前期高风险女性的心血管风险评估
前瞻性队列研究纳入西班牙单中心349例孕早期筛查孕妇,以1/250为切点分为子痫前期高风险组257例与低风险组92例,比较孕中期超声心动图及血液标志物。高风险组呈现更差的脂质谱、更低的胎盘生长因子中位数倍数和更低的N末端B型利钠肽原水平,超声心动图提示向心性重构及舒张模式改变。
要点
- 子痫前期高风险孕妇在妊娠前半期已出现超声心动图向心性重构和舒张功能改变。
- 高风险组胎盘生长因子中位数倍数更低(0.89 vs 1.15,P<0.001)。
- 高风险组高密度脂蛋白更低(69.7 vs 74.0 mg/dL,P=0.020)。
核心结论
- 子痫前期高风险女性在妊娠前半期即表现出脂质谱、血管生成因子及超声心动图参数的差异,提示心脏适应不良或功能受损,这些发现似乎将亚临床心血管功能障碍、子痫前期发生与远期心血管疾病风险联系起来。
研究设计与样本
- 前瞻性队列研究,纳入2020年7月至2023年4月在西班牙单中心接受孕早期子痫前期筛查的孕妇349例,高风险257例、低风险92例;孕早期风险采用包含母体因素和生物物理标志物的既往验证模型计算,以1/250为高风险切点;评估母体超声心动图功能与形态,并采集外周血检测血液学与生化指标,包括脂质谱及心血管和血管生成因子;比较高风险与低风险组间的差异。
关键影像表现/征象
- 超声心动图评估提示高风险组呈现向心性重构并伴舒张模式改变。
诊断标准与关键数值
- 孕早期子痫前期风险采用既往验证模型计算,以1/250为切点分类高风险。
- 高风险组高密度脂蛋白为69.7 ± 14.2 mg/dL,低风险组为74.0 ± 14.6 mg/dL(P = 0.020)。
- 高风险组胎盘生长因子中位数倍数为0.89 ± 0.63,低风险组为1.15 ± 0.58(P < 0.001)。
- 高风险组N末端B型利钠肽原为51.0 ± 2.1 ng/L,低风险组为52.1 ± 2.0 ng/L(P = 0.008)。
临床应用与阅片要点
- 对子痫前期高风险孕妇,除常规筛查外可关注超声心动图是否出现向心性重构及舒张模式改变。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Women diagnosed with pre-eclampsia (PE), especially those with early-onset and severe forms, are at heightened risk of future cardiovascular disease. However, it is uncertain if women at high risk for PE present cardiovascular impairment at the beginning of pregnancy. The aim of this study was to assess cardiovascular biomarkers and cardiac function in the first half of pregnancy in women at high risk for PE.
METHODS: This was a prospective cohort study including women attending first-trimester screening for PE at a single center in Spain, between July 2020 and April 2023. The risk of PE in the first trimester was calculated using a previously validated model that includes maternal factors and biophysical markers. A cut-off of 1 in 250 was used to classify high risk for developing PE. Maternal echocardiographic function and morphometry were evaluated, and peripheral blood samples were obtained to assess hematological and biochemical variables, including lipid profile and cardiovascular and angiogenic factors. Findings were compared between women at high risk and those at low risk for PE.
RESULTS: A total of 349 pregnant individuals were included, 257 at high risk and 92 at low risk for PE. Maternal echocardiography was performed at a mean ± SD gestational age of 14.9 ± 1.3 weeks and blood sampling at 16.3 ± 1.9 weeks. The high-risk PE group exhibited a worse lipid profile (significantly lower levels of high-density lipoprotein (69.7 ± 14.2 vs 74.0 ± 14.6 mg/dL; P = 0.020), significantly lower placental growth factor multiples of the median (0.89 ± 0.63 vs 1.15 ± 0.58; P < 0.001) and significantly lower levels of N-terminal pro B-type natriuretic peptide (51.0 ± 2.1 vs 52.1 ± 2.0 ng/L; P = 0.008)). Echocardiographic evaluation indicated concentric remodeling along with an altered diastolic pattern in the high-risk group.
CONCLUSIONS: Women at high risk of developing PE exhibit differences in lipid profile, angiogenic factors and echocardiographic parameters, indicative of cardiac maladaptation or impairment during the first half of pregnancy. These findings suggest a link between subclinical cardiovascular dysfunction, PE development and later cardiovascular disease risk. © 2025 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Ullmo J, Cruz-Lemini M, Bos-Real L, et al. Cardiovascular risk assessment in women at high risk for pre-eclampsia in first half of pregnancy. Ultrasound Obstet Gynecol. 2025. PMID: 40471220. doi:10.1002/uog.29247
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。